Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,790 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.
Masuda H, Kobayashi T, Hachiya A, Nakashima Y, Shimizu H, Nozawa T, Ogihara Y, Ito S, Takatsuki S, Katsumata N, Suzuki Y, Takenaka S, Hirono K, Kobayashi T, Suzuki H, Suganuma E, Takahashi K, Saji T; Committee of Survey on Infliximab use for Kawasaki disease. Masuda H, et al. Among authors: suzuki h, suzuki y. J Pediatr. 2018 Apr;195:115-120.e3. doi: 10.1016/j.jpeds.2017.10.013. Epub 2017 Dec 7. J Pediatr. 2018. PMID: 29224935
Remission of autoimmune neutropenia after development of Kawasaki disease.
Okada S, Hasegawa S, Suzuki Y, Ichimura T, Kaneyasu H, Shimomura M, Wakabayashi-Takahara M, Nakamura K, Kobayashi M, Ohga S. Okada S, et al. Among authors: suzuki y. Pediatr Int. 2015 Oct;57(5):1012-4. doi: 10.1111/ped.12701. Epub 2015 Sep 10. Pediatr Int. 2015. PMID: 26508185
Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
Kibata T, Suzuki Y, Hasegawa S, Matsushige T, Kusuda T, Hoshide M, Takahashi K, Okada S, Wakiguchi H, Moriwake T, Uchida M, Ohbuchi N, Iwai T, Hasegawa M, Ichihara K, Yashiro M, Makino N, Nakamura Y, Ohga S. Kibata T, et al. Among authors: suzuki y. Int J Cardiol. 2016 Jul 1;214:209-15. doi: 10.1016/j.ijcard.2016.03.017. Epub 2016 Mar 28. Int J Cardiol. 2016. PMID: 27070994
Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial.
Mori M, Hara T, Kikuchi M, Shimizu H, Miyamoto T, Iwashima S, Oonishi T, Hashimoto K, Kobayashi N, Waki K, Suzuki Y, Otsubo Y, Yamada H, Ishikawa C, Kato T, Fuse S. Mori M, et al. Among authors: suzuki y. Sci Rep. 2018 Jan 31;8(1):1994. doi: 10.1038/s41598-017-18387-7. Sci Rep. 2018. PMID: 29386515 Free PMC article. Clinical Trial.
16,790 results
You have reached the last available page of results. Please see the User Guide for more information.